DK3600278T3 - Statin til forebyggelse/reduktion af iskæmi-relateret skade - Google Patents
Statin til forebyggelse/reduktion af iskæmi-relateret skade Download PDFInfo
- Publication number
- DK3600278T3 DK3600278T3 DK18715625.2T DK18715625T DK3600278T3 DK 3600278 T3 DK3600278 T3 DK 3600278T3 DK 18715625 T DK18715625 T DK 18715625T DK 3600278 T3 DK3600278 T3 DK 3600278T3
- Authority
- DK
- Denmark
- Prior art keywords
- statin
- chemistry
- ice
- prevention
- reduction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17164137.6A EP3381452A1 (en) | 2017-03-31 | 2017-03-31 | Statin for prevention/reduction of ischemia-related damage |
| ES201730736 | 2017-05-26 | ||
| PCT/EP2018/058158 WO2018178275A1 (en) | 2017-03-31 | 2018-03-29 | Statin for prevention/reduction of ischemia-related damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3600278T3 true DK3600278T3 (da) | 2021-04-26 |
Family
ID=61899251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18715625.2T DK3600278T3 (da) | 2017-03-31 | 2018-03-29 | Statin til forebyggelse/reduktion af iskæmi-relateret skade |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20200030288A1 (da) |
| EP (1) | EP3600278B1 (da) |
| CN (1) | CN110494134A (da) |
| BR (1) | BR112019020353A2 (da) |
| CA (1) | CA3058250A1 (da) |
| DK (1) | DK3600278T3 (da) |
| ES (1) | ES2877646T3 (da) |
| MX (1) | MX2019011567A (da) |
| PL (1) | PL3600278T3 (da) |
| RU (1) | RU2768889C2 (da) |
| WO (1) | WO2018178275A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112516126A (zh) * | 2020-11-20 | 2021-03-19 | 南方医科大学南方医院 | 普伐他汀的新用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999010499A1 (en) | 1997-08-22 | 1999-03-04 | Dsm N.V. | Statin production by fermentation |
| IL165253A0 (en) * | 2002-05-17 | 2005-12-18 | Esperion Therapeutics Inc | Methods and compositions for the treatment of ischemic reperfusion |
| US7166638B2 (en) | 2003-05-27 | 2007-01-23 | Nicox S.A. | Statin derivatives |
| CN100502870C (zh) * | 2005-07-07 | 2009-06-24 | 安徽省现代中药研究中心 | 含有瑞舒伐他汀或匹伐他汀和b族维生素的药物组合物 |
| BRPI0706757A2 (pt) * | 2006-01-30 | 2011-04-05 | Israel Ben David Bryson | composições e métodos para tratar pacientes com doença cardiovascular, cerebrovascular e outra doença vascular |
| US8183397B2 (en) | 2007-04-03 | 2012-05-22 | Lek Pharmaceuticals D.D. | Synthesis of statins |
| US20110054193A1 (en) | 2008-04-29 | 2011-03-03 | Marco Alexander Van Den Berg | Statin production |
| EP2334781A1 (en) | 2008-09-24 | 2011-06-22 | DSM IP Assets B.V. | Improved statin production |
| US10028975B2 (en) * | 2010-10-19 | 2018-07-24 | Beth Israel Deaconess Medical Center, Inc. | Methods for treating ischemia-reperfusion injury |
| EP2949324A1 (en) * | 2014-05-27 | 2015-12-02 | Consorci Institut Catala de Ciencies Cardiovasculars | Prevention and/or treatment of ischemia/reperfusion injury |
-
2018
- 2018-03-29 RU RU2019134491A patent/RU2768889C2/ru active
- 2018-03-29 BR BR112019020353A patent/BR112019020353A2/pt unknown
- 2018-03-29 PL PL18715625T patent/PL3600278T3/pl unknown
- 2018-03-29 DK DK18715625.2T patent/DK3600278T3/da active
- 2018-03-29 EP EP18715625.2A patent/EP3600278B1/en active Active
- 2018-03-29 US US16/498,813 patent/US20200030288A1/en active Pending
- 2018-03-29 CA CA3058250A patent/CA3058250A1/en active Pending
- 2018-03-29 ES ES18715625T patent/ES2877646T3/es active Active
- 2018-03-29 MX MX2019011567A patent/MX2019011567A/es unknown
- 2018-03-29 CN CN201880023430.1A patent/CN110494134A/zh active Pending
- 2018-03-29 WO PCT/EP2018/058158 patent/WO2018178275A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018178275A1 (en) | 2018-10-04 |
| PL3600278T3 (pl) | 2021-08-02 |
| RU2019134491A (ru) | 2021-04-30 |
| EP3600278A1 (en) | 2020-02-05 |
| BR112019020353A2 (pt) | 2020-04-28 |
| CN110494134A (zh) | 2019-11-22 |
| EP3600278B1 (en) | 2021-01-27 |
| MX2019011567A (es) | 2020-01-21 |
| US20200030288A1 (en) | 2020-01-30 |
| RU2019134491A3 (da) | 2021-07-16 |
| ES2877646T3 (es) | 2021-11-17 |
| RU2768889C2 (ru) | 2022-03-25 |
| CA3058250A1 (en) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54543A (fr) | Inhibiteurs de kif18a | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| DK3512850T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3468966T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3371171T3 (da) | Inhibitorer af RET | |
| DK3377059T3 (da) | Hæmmere af cxcr2 | |
| DK3317400T3 (da) | Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter | |
| DK3661921T3 (da) | Selektive hæmmere af nlrp3-inflammasom | |
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| DK3212778T3 (da) | Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| MA52812A (fr) | Inhibiteurs de sarm1 | |
| DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3668851T3 (da) | Fremgangsmåde til fremstilling af thiocarbonater | |
| DK3506747T3 (da) | Fremgangsmåde til reducering af skade på afgrøder | |
| DK3551625T3 (da) | Heterocykliske inhibitorer af mct4 | |
| DK3368683T3 (da) | Fremgangsmåde til kvantifikationen af pd-l1 | |
| DK3512857T3 (da) | Spiro-bicykliske inhibitorer af menin-mll-interaktion | |
| DK3519572T3 (da) | Forbindelser og fremgangsmåder til reduktion af tau-ekspression | |
| DK3571192T3 (da) | Jak1-selektive inhibitorer | |
| DK3513617T3 (da) | Håndtering af PDCP under genetablering af forbindelse | |
| DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| DK3512833T3 (da) | Heteroarylcarboxamidforbindelser som inhibitorer af ripk2 | |
| MA52809A (fr) | Inhibiteurs de sarm1 |